Search - tctmd.com

Displaying 81 - 100 of 216

Sort: Relevancy | Date

News Daily News

Injectable P2Y12 Inhibitor Selatogrel Shows Promise in Acute MI

Yael L. Maxwell

June 03, 2020

News Daily News

P2Y12 Inhibitor Monotherapy Edges Out Aspirin for Secondary Prevention

Yael L. Maxwell

May 15, 2020

News Conference News ACC 2020

TICO: Ticagrelor Monotherapy After 3 Months of DAPT Curbs Bleeding in Stented ACS Patients

Todd Neale

March 31, 2020

News Conference News ACC 2020

Safety, Efficacy of Ticagrelor Monotherapy Confirmed in Complex PCI, Diabetes

Yael L. Maxwell

March 30, 2020

News Daily News

Better Adherence to Guideline Advice Pays Off After Acute MI

Yael L. Maxwell

March 11, 2020

News Daily News

Potent Antithrombotic Therapy Cuts Spontaneous MI After PCI for ACS

Yael L. Maxwell

March 10, 2020

News Daily News

New ABCD-GENE Score Taps Clinical, Genetic Factors to ID Clopidogrel Nonresponders

Yael L. Maxwell

March 06, 2020

News Daily News

Type 2 MI Linked to More CV Deaths, Even in Younger Patients

Shelley Wood

March 04, 2020

News Daily News

No Fewer MACE With Ticagrelor vs Clopidogrel in ACS Patients After PCI: Registry

Todd Neale

January 15, 2020

News Daily News

CV Risk Factors Largely Explain Sex Gap in NSTE ACS Outcomes: TIMI Trials

Caitlin E. Cox

December 11, 2019

News Conference News AHA 2019

Aspirin Discontinuation Safe, Effective Strategy in ACS Subset: TWILIGHT

Yael L. Maxwell

November 17, 2019

News Daily News

Women Bleed More Than Men After PCI, GLOBAL LEADERS Affirms

Todd Neale

November 07, 2019

News Daily News

Morphine Not Linked to Increased Short-term Mortality in STEMI: Meta-analysis

L.A. McKeown

November 01, 2019

Presentation TCT Abstracts Posters 2019

Comparison of Real-World Bleeding and Ischemic Event Rate in P2Y12 Inhibitors After Percutaneous Coronary Intervention: Analysis of Korean National Insurance Claims Data

Presenter: Young-Hyo Lim

October 21, 2019

Presentation TCT Abstracts Posters 2019

Comparison of Real-World Bleeding and Ischemic Event Rate in P2Y12 Inhibitors After Percutaneous Coronary Intervention: Analysis of Korean National Insurance Claims Data

Presenter: Young-Hyo Lim

September 29, 2019

Presentation TCT 2019

Case Resolution: How Did I Treat and What Happened?

Presenter: Amit Vora

September 26, 2019

Presentation TCT 2019

The Approach to the High Bleeding Risk Patient: The Dos and the Don’ts!

Presenter: Bernard Chevalier

September 26, 2019

Presentation TCT 2019

Long-Term Antithrombotic Therapy After PCI: How Do I Incorporate COMPASS Into My Practice?

Presenter: Robert Welsh

September 26, 2019

Presentation TCT 2019

De-Escalation: When and How? — The Role of Platelet Function and Genetic Testing

Presenter: Francesco Franchi

September 26, 2019

News Conference News TCT 2019

TWILIGHT: Ticagrelor Monotherapy Lowers Bleeding Without Increasing Ischemic Events

Yael L. Maxwell

September 26, 2019

Advertisement

Injectable P2Y12 Inhibitor Selatogrel Shows Promise in Acute MI

P2Y12 Inhibitor Monotherapy Edges Out Aspirin for Secondary Prevention

TICO: Ticagrelor Monotherapy After 3 Months of DAPT Curbs Bleeding in Stented ACS Patients

Safety, Efficacy of Ticagrelor Monotherapy Confirmed in Complex PCI, Diabetes

Better Adherence to Guideline Advice Pays Off After Acute MI

Potent Antithrombotic Therapy Cuts Spontaneous MI After PCI for ACS

New ABCD-GENE Score Taps Clinical, Genetic Factors to ID Clopidogrel Nonresponders

Type 2 MI Linked to More CV Deaths, Even in Younger Patients

No Fewer MACE With Ticagrelor vs Clopidogrel in ACS Patients After PCI: Registry

CV Risk Factors Largely Explain Sex Gap in NSTE ACS Outcomes: TIMI Trials

Aspirin Discontinuation Safe, Effective Strategy in ACS Subset: TWILIGHT

Women Bleed More Than Men After PCI, GLOBAL LEADERS Affirms

Morphine Not Linked to Increased Short-term Mortality in STEMI: Meta-analysis

Comparison of Real-World Bleeding and Ischemic Event Rate in P2Y12 Inhibitors After Percutaneous Coronary Intervention: Analysis of Korean National Insurance Claims Data

Comparison of Real-World Bleeding and Ischemic Event Rate in P2Y12 Inhibitors After Percutaneous Coronary Intervention: Analysis of Korean National Insurance Claims Data

Case Resolution: How Did I Treat and What Happened?

The Approach to the High Bleeding Risk Patient: The Dos and the Don’ts!

Long-Term Antithrombotic Therapy After PCI: How Do I Incorporate COMPASS Into My Practice?

De-Escalation: When and How? — The Role of Platelet Function and Genetic Testing

TWILIGHT: Ticagrelor Monotherapy Lowers Bleeding Without Increasing Ischemic Events

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content